Anti-corruption, Compliance Scrutiny Increases In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Anti-corruptions officials - whose interests are not scientific but regulatory - have started paying increasing attention to the life sciences sector in recent years